Cargando…

Clinical evaluation of switching from immediate‐release to prolonged‐release lithium in bipolar patients, poorly tolerant to lithium immediate‐release treatment: A randomized clinical trial

AIM: The effect of switching from lithium immediate release (Li‐IR) to lithium prolonged release (Li‐PR) on lithium‐induced tremor after 1 and 12 weeks of treatment was evaluated in a randomized, multicenter, open trial, in bipolar patients from the participating sites with a tremor severity ≥2 (Udv...

Descripción completa

Detalles Bibliográficos
Autores principales: Pelacchi, Federica, Dell'Osso, Liliana, Bondi, Emi, Amore, Mario, Fagiolini, Andrea, Iazzetta, Paolo, Pierucci, Daniela, Gorini, Manuela, Quarchioni, Elisa, Comandini, Alessandro, Salvatori, Enrica, Cattaneo, Agnese, Pompili, Maurizio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8933786/
https://www.ncbi.nlm.nih.gov/pubmed/35137572
http://dx.doi.org/10.1002/brb3.2485
_version_ 1784671732955611136
author Pelacchi, Federica
Dell'Osso, Liliana
Bondi, Emi
Amore, Mario
Fagiolini, Andrea
Iazzetta, Paolo
Pierucci, Daniela
Gorini, Manuela
Quarchioni, Elisa
Comandini, Alessandro
Salvatori, Enrica
Cattaneo, Agnese
Pompili, Maurizio
author_facet Pelacchi, Federica
Dell'Osso, Liliana
Bondi, Emi
Amore, Mario
Fagiolini, Andrea
Iazzetta, Paolo
Pierucci, Daniela
Gorini, Manuela
Quarchioni, Elisa
Comandini, Alessandro
Salvatori, Enrica
Cattaneo, Agnese
Pompili, Maurizio
author_sort Pelacchi, Federica
collection PubMed
description AIM: The effect of switching from lithium immediate release (Li‐IR) to lithium prolonged release (Li‐PR) on lithium‐induced tremor after 1 and 12 weeks of treatment was evaluated in a randomized, multicenter, open trial, in bipolar patients from the participating sites with a tremor severity ≥2 (Udvalg for Kliniske Undersøgelser [UKU] rating scale) despite optimal lithium titration. METHODS: The primary endpoint was the evaluation of tremor by means of the UKU scale after 1 week of treatment. Secondary endpoints included manic Young Mania Rating Scale (YMRS) and depressive symptoms (Montgomery–Asberg Depression Rating Scale), a global assessment of the patient's status (Clinical Global Impression), polyuria/polydipsia (UKU item 3.8) and patient‐reported outcomes. RESULTS: Owing to difficulties in including suitable patients the enrollment phase was closed when 73 patients were randomized. Notwithstanding the lower number of patients, in the modified intention‐to‐treat population (n = 70) the primary endpoint was statistically significant: tremor improved after 1 week in 62.9% in Li‐PR group against 20.0% of patients in Li‐IR group (p = .0006; two‐tailed Fisher's exact test). The difference remained statistically significant after 4 (p = .0031) and 12 weeks (p = .0128). The same analysis performed in the PP population confirmed these results. Among the secondary endpoints, only the factor convenience of the treatment satisfaction questionnaire showed a statistically significant difference between groups. There were no apparent differences in the safety profile of the two formulations. CONCLUSIONS: This study is the first comparative documentation of a potential benefit of the prolonged‐release formulation in reducing the symptom tremor, a well‐known adverse effect of lithium therapy. Indeed, the study results should be interpreted taking into account the sample size lower than planned.
format Online
Article
Text
id pubmed-8933786
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-89337862022-03-24 Clinical evaluation of switching from immediate‐release to prolonged‐release lithium in bipolar patients, poorly tolerant to lithium immediate‐release treatment: A randomized clinical trial Pelacchi, Federica Dell'Osso, Liliana Bondi, Emi Amore, Mario Fagiolini, Andrea Iazzetta, Paolo Pierucci, Daniela Gorini, Manuela Quarchioni, Elisa Comandini, Alessandro Salvatori, Enrica Cattaneo, Agnese Pompili, Maurizio Brain Behav Registered Report Stage 2 AIM: The effect of switching from lithium immediate release (Li‐IR) to lithium prolonged release (Li‐PR) on lithium‐induced tremor after 1 and 12 weeks of treatment was evaluated in a randomized, multicenter, open trial, in bipolar patients from the participating sites with a tremor severity ≥2 (Udvalg for Kliniske Undersøgelser [UKU] rating scale) despite optimal lithium titration. METHODS: The primary endpoint was the evaluation of tremor by means of the UKU scale after 1 week of treatment. Secondary endpoints included manic Young Mania Rating Scale (YMRS) and depressive symptoms (Montgomery–Asberg Depression Rating Scale), a global assessment of the patient's status (Clinical Global Impression), polyuria/polydipsia (UKU item 3.8) and patient‐reported outcomes. RESULTS: Owing to difficulties in including suitable patients the enrollment phase was closed when 73 patients were randomized. Notwithstanding the lower number of patients, in the modified intention‐to‐treat population (n = 70) the primary endpoint was statistically significant: tremor improved after 1 week in 62.9% in Li‐PR group against 20.0% of patients in Li‐IR group (p = .0006; two‐tailed Fisher's exact test). The difference remained statistically significant after 4 (p = .0031) and 12 weeks (p = .0128). The same analysis performed in the PP population confirmed these results. Among the secondary endpoints, only the factor convenience of the treatment satisfaction questionnaire showed a statistically significant difference between groups. There were no apparent differences in the safety profile of the two formulations. CONCLUSIONS: This study is the first comparative documentation of a potential benefit of the prolonged‐release formulation in reducing the symptom tremor, a well‐known adverse effect of lithium therapy. Indeed, the study results should be interpreted taking into account the sample size lower than planned. John Wiley and Sons Inc. 2022-02-09 /pmc/articles/PMC8933786/ /pubmed/35137572 http://dx.doi.org/10.1002/brb3.2485 Text en © 2022 The Authors. Brain and Behavior published by Wiley Periodicals LLC https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Registered Report Stage 2
Pelacchi, Federica
Dell'Osso, Liliana
Bondi, Emi
Amore, Mario
Fagiolini, Andrea
Iazzetta, Paolo
Pierucci, Daniela
Gorini, Manuela
Quarchioni, Elisa
Comandini, Alessandro
Salvatori, Enrica
Cattaneo, Agnese
Pompili, Maurizio
Clinical evaluation of switching from immediate‐release to prolonged‐release lithium in bipolar patients, poorly tolerant to lithium immediate‐release treatment: A randomized clinical trial
title Clinical evaluation of switching from immediate‐release to prolonged‐release lithium in bipolar patients, poorly tolerant to lithium immediate‐release treatment: A randomized clinical trial
title_full Clinical evaluation of switching from immediate‐release to prolonged‐release lithium in bipolar patients, poorly tolerant to lithium immediate‐release treatment: A randomized clinical trial
title_fullStr Clinical evaluation of switching from immediate‐release to prolonged‐release lithium in bipolar patients, poorly tolerant to lithium immediate‐release treatment: A randomized clinical trial
title_full_unstemmed Clinical evaluation of switching from immediate‐release to prolonged‐release lithium in bipolar patients, poorly tolerant to lithium immediate‐release treatment: A randomized clinical trial
title_short Clinical evaluation of switching from immediate‐release to prolonged‐release lithium in bipolar patients, poorly tolerant to lithium immediate‐release treatment: A randomized clinical trial
title_sort clinical evaluation of switching from immediate‐release to prolonged‐release lithium in bipolar patients, poorly tolerant to lithium immediate‐release treatment: a randomized clinical trial
topic Registered Report Stage 2
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8933786/
https://www.ncbi.nlm.nih.gov/pubmed/35137572
http://dx.doi.org/10.1002/brb3.2485
work_keys_str_mv AT pelacchifederica clinicalevaluationofswitchingfromimmediatereleasetoprolongedreleaselithiuminbipolarpatientspoorlytoleranttolithiumimmediatereleasetreatmentarandomizedclinicaltrial
AT dellossoliliana clinicalevaluationofswitchingfromimmediatereleasetoprolongedreleaselithiuminbipolarpatientspoorlytoleranttolithiumimmediatereleasetreatmentarandomizedclinicaltrial
AT bondiemi clinicalevaluationofswitchingfromimmediatereleasetoprolongedreleaselithiuminbipolarpatientspoorlytoleranttolithiumimmediatereleasetreatmentarandomizedclinicaltrial
AT amoremario clinicalevaluationofswitchingfromimmediatereleasetoprolongedreleaselithiuminbipolarpatientspoorlytoleranttolithiumimmediatereleasetreatmentarandomizedclinicaltrial
AT fagioliniandrea clinicalevaluationofswitchingfromimmediatereleasetoprolongedreleaselithiuminbipolarpatientspoorlytoleranttolithiumimmediatereleasetreatmentarandomizedclinicaltrial
AT iazzettapaolo clinicalevaluationofswitchingfromimmediatereleasetoprolongedreleaselithiuminbipolarpatientspoorlytoleranttolithiumimmediatereleasetreatmentarandomizedclinicaltrial
AT pieruccidaniela clinicalevaluationofswitchingfromimmediatereleasetoprolongedreleaselithiuminbipolarpatientspoorlytoleranttolithiumimmediatereleasetreatmentarandomizedclinicaltrial
AT gorinimanuela clinicalevaluationofswitchingfromimmediatereleasetoprolongedreleaselithiuminbipolarpatientspoorlytoleranttolithiumimmediatereleasetreatmentarandomizedclinicaltrial
AT quarchionielisa clinicalevaluationofswitchingfromimmediatereleasetoprolongedreleaselithiuminbipolarpatientspoorlytoleranttolithiumimmediatereleasetreatmentarandomizedclinicaltrial
AT comandinialessandro clinicalevaluationofswitchingfromimmediatereleasetoprolongedreleaselithiuminbipolarpatientspoorlytoleranttolithiumimmediatereleasetreatmentarandomizedclinicaltrial
AT salvatorienrica clinicalevaluationofswitchingfromimmediatereleasetoprolongedreleaselithiuminbipolarpatientspoorlytoleranttolithiumimmediatereleasetreatmentarandomizedclinicaltrial
AT cattaneoagnese clinicalevaluationofswitchingfromimmediatereleasetoprolongedreleaselithiuminbipolarpatientspoorlytoleranttolithiumimmediatereleasetreatmentarandomizedclinicaltrial
AT pompilimaurizio clinicalevaluationofswitchingfromimmediatereleasetoprolongedreleaselithiuminbipolarpatientspoorlytoleranttolithiumimmediatereleasetreatmentarandomizedclinicaltrial
AT clinicalevaluationofswitchingfromimmediatereleasetoprolongedreleaselithiuminbipolarpatientspoorlytoleranttolithiumimmediatereleasetreatmentarandomizedclinicaltrial